Androgen receptor is a tumor suppressor and proliferator in prostate cancer.

Proceedings of the National Academy of Sciences of the United States of America
Yuanjie NiuChawnshang Chang

Abstract

Targeting androgens/androgen receptor (AR) functions via androgen deprivation therapy (ADT) remains the standard treatment for prostate cancer. However, most tumors eventually recur despite ADT. Here we demonstrate that the prostate AR may function as both a suppressor and a proliferator to suppress or promote prostate cancer metastasis. Results from orthotopically recombining stromal WPMY1 cells with epithelial PC3 prostate cancer cells in mice demonstrated that restoring AR in epithelial PC3 cells or knockdown of AR in stromal WPMY1 cells suppressed prostate cancer metastasis. Knockdown of the AR in epithelial CWR22rv1 prostate cancer cells also resulted in increased cell invasion in vitro and in vivo. Restoring AR in PC3 cells (PC3-AR9) results in decreased invasion in bone lesion assays and in vivo mouse models. Mice lacking the prostate epithelial AR have increased apoptosis in epithelial luminal cells and increased proliferation in epithelial basal cells. The consequences of these two contrasting results led to the expansion of CK5/CK8-positive intermediate cells, and mice developed larger and more invasive metastatic tumors in lymph nodes and died earlier than wild-type littermates. Mechanistic dissection suggested that ...Continue Reading

References

Apr 1, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·B Grasl-KrauppR Schulte-Hermann
Aug 10, 2000·Neoplasia : an International Journal for Oncology Research·U PilatusZ M Bhujwalla
Dec 18, 2001·The Journal of Pathology·G J van LeendersJ A Schalken
Mar 29, 2002·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·J Jeffrey GoaterEdward M Schwarz
Jul 5, 2003·The Journal of Clinical Endocrinology and Metabolism·Ivan V LitvinovJohn T Isaacs
Apr 15, 2004·Endocrine Reviews·Cynthia A Heinlein, Chawnshang Chang
Apr 28, 2004·The American Journal of Pathology·Bernard GarySarki A Abdulkadir
Nov 3, 2005·Nature Clinical Practice. Oncology·Hiroshi MiyamotoChawnshang Chang
Jan 11, 2007·Genesis : the Journal of Genetics and Development·Mo ChenDi Chen
Apr 17, 2007·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·Stephan H FlüchterChristoph Gamper
Jul 27, 2007·Proceedings of the National Academy of Sciences of the United States of America·Chun-Te WuChawnshang Chang
Aug 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Yuanjie NiuChawnshang Chang

❮ Previous
Next ❯

Citations

Jun 15, 2010·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Miao-Fen ChenChun-Te Wu
Dec 18, 1995·Biochimica Et Biophysica Acta·L MaA J van der Eb
May 19, 2010·Cell Research·Bradley GodfreyJialing Xiang
Aug 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Yuanjie NiuChawnshang Chang
Apr 27, 2011·Proceedings of the National Academy of Sciences of the United States of America·Sanaz MemarzadehOwen N Witte
Dec 4, 2009·Molecular & Cellular Proteomics : MCP·Amjad P KhanArun Sreekumar
Sep 17, 2010·Genes & Development·Michael M Shen, Cory Abate-Shen
Dec 14, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Vassiliki TzelepiAna M Aparicio
May 25, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vassiliki TzelepiLance C Pagliaro
Jan 7, 2014·PloS One·LaTanya V WilliamsOlga V Volpert
Mar 7, 2012·The Journal of Endocrinology·Soo Ok LeeChawnshang Chang
Jul 24, 2013·International Journal of Oncology·Tiancheng LiuClifford E Berkman
Dec 4, 2013·International Journal of Oncology·Tiancheng LiuClifford E Berkman
May 22, 2009·Proceedings of the National Academy of Sciences of the United States of America·Vijayabaskar LakshmikanthanYehia Daaka
Jun 21, 2014·BioMed Research International·Rengjing ZhangXiaobo Zhou
Feb 8, 2011·Journal of Endocrinological Investigation·G CoronaM Maggi
Nov 26, 2015·Clinical Investigation·Kouji IzumiChawnshang Chang
Feb 11, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eleni Efstathiou, Christopher J Logothetis
Mar 2, 2013·Molecular Endocrinology·Wenfu LuZhenbang Chen
Apr 22, 2015·Seminars in Cancer Biology·Mark A FeitelsonSomaira Nowsheen
Dec 19, 2014·Cancers·Yasuyoshi MiyataHideki Sakai
Jan 6, 2010·Expert Opinion on Investigational Drugs·Lei LiDalin He
Feb 19, 2016·Epigenetics : Official Journal of the DNA Methylation Society·Brittany KlebAna Aparicio

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis